Skip to Accessibility Menu Skip to Login Skip to Content Skip to Footer

Must-Reads for Anyone with Non-Muscle Invasive Bladder Cancer

Deciding on A Treatment for Early-Stage Bladder Cancer

One of the most challenging aspects of bladder cancer is deciding on a treatment path when the diagnosis is Stage T1, high grade. This staging means the tumor has grown...

What is Non-Muscle Invasive Bladder Cancer?

There are several different types of bladder cancer, but the most common type is called urothelial carcinoma...

What I Wish I’d Known Before Being Diagnosed

In January 2017, I began my bladder cancer journey with an official diagnosis: low-grade, low-stageurothelial carcinoma. But in reality, my bladder cancer journey had started months and months before my...

Before, During & After BCG: What to Expect

Bacillus Calmette-Guérin (BCG) is an immunotherapy used to treat bladder cancer. BCG treatment is made from a bacterium and is also used as a vaccine for tuberculosis.1,2 It is known...

FDA Approves New Non-Muscle Invasive Bladder Cancer Treatment

For the first time in 20 years, the US Food and Drug Administration (FDA) has approved a new treatment for non-muscle invasive bladder cancer (NMIBC). The drug pembrolizumab is marketed...

Fighting to Keep My Bladder

I sometimes wonder if I’m standing alone when it comes to the choice of removing your bladder to avoid any chance of your cancer spreading. I have huge respect for...

The Difference Between Mitomycin and BCG

Occasionally, there is some confusion within the bladder cancer community between two common treatments: Bacillus Calmette-Guerin (BCG) and Mitomycin. They are both intravesical therapies, meaning that they are treatments that...

Making Treatment Decisions

Cancer treatment is a buffet of choices. Each one comes with a bounty of pros and cons. When I was diagnosed, my urologist talked to me about grade and staging...